Altogether, this evidence suggests a critical role of extracellular ADO in tumorigenesis and the PD-1/PD-L1 axis dysregulation in CD38-positive cancers; however, this approach has yet to be explored in depth in mature B-cell neoplasm patients. The gene discussed is ADO; the disease is cancer.